Clinical effects of natalizumab on multiple sclerosis appear early in treatment course-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical effects of natalizumab on multiple sclerosis appear early in treatment course

Published:2013-01-05 Issue:5 Volume:260 Page:1388-1395
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Kappos Ludwig,O’Connor Paul W.,Polman Christopher H.,Vermersch Patrick,Wiendl Heinz,Pace Amy,Zhang Annie,Hotermans Christophe

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

http://link.springer.com/article/10.1007/s00415-012-6809-7/fulltext.html

Reference38 articles.

1. Caon C (2009) Maximising therapeutic outcomes in patients failing on current therapy. J Neurol Sci 277(Suppl 1):S33–S36

2. Boster A, Edan G, Frohman E, Javed A, Stuve O, Tselis A, Weiner H, Weinstock-Guttman B, Khan O, Multiple Sclerosis Clinical Research Center DoNWSUSoM (2008) Intense immunosuppression in patients with rapidly worsening multiple sclerosis: treatment guidelines for the clinician. Lancet Neurol 7(2):173–183

3. Comi G (2009) Shifting the paradigm toward earlier treatment of multiple sclerosis with interferon beta. Clin Ther 31(6):1142–1157

4. Coyle PK, Hartung HP (2002) Use of interferon beta in multiple sclerosis: rationale for early treatment and evidence for dose- and frequency-dependent effects on clinical response. Mult Scler 8(1):2–9

5. Tintore M (2008) Rationale for early intervention with immunomodulatory treatments. J Neurol 255(Suppl 1):37–43

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of multiple sclerosis: Epidemiology, etiology, pathophysiology, and treatment;Medicine;2024-02-23

2. Comparison of time to clinically meaningful improvement in quality of life in neurological disorders in patients treated with natalizumab versus ocrelizumab;Neurodegenerative Disease Management;2024-01-02

3. Patient-reported outcomes based on discontinuation or continuous treatment with natalizumab: New York State Multiple Sclerosis Consortium (NYSMSC) study;Journal of the Neurological Sciences;2023-12

4. Practical Clinical Guidelines for Natalizumab Treatment in Patients With Relapsing Multiple Sclerosis;Journal of Infusion Nursing;2023-11

5. Systematic review of gender bias in clinical trials of monoclonal antibodies for the treatment of multiple sclerosis;Neurología (English Edition);2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3